Mirikizumab (Omvoh™) for ulcerative colitis

Research output: Contribution to journal › Journal article › Research › peer-review

Presentation
Citation formats

Alexander Hammerhøj
Theresa Louise Boye
Langholz, Ebbe
Nielsen, Ole Haagen

STRUCTURE: Mirikizumab is a humanized IgG4-variant monoclonal antibody consisting of two heavy-chain and two light-chain subunits. Mirikizumab binds with high affinity to the p19 subunit (α subunit) of the heterodimeric interleukin-23 (IL-23).

Original language	English
Journal	Trends in Pharmacological Sciences
Volume	45
Issue number	3
Pages (from-to)	281-282
Number of pages	2
ISSN	0165-6147
DOIs	https://doi.org/10.1016/j.tips.2024.01.001
Publication status	Published - 2024

ID: 380697148